MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hormone therapy'. Sat, 03 Sep 2011 02:20:56 +0100 http://www.medworm.com/index.php?rid=3641020&cid=t_127677_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fprostate-cancer-what-you-should-know%2F2010.06.08 When Dennis Hopper died of prostate cancer at age 74, my husband asked me: “Hey, I thought prostate cancer is slow-growing and doesn’t kill men.” Well, he’s right about it usually being slow-growing, but prostate cancer is still the second leading cause of cancer death in men. His question made me realize that there are some facts that everyone should know about prostate cancer. (more…) *This blog post was originally published at EverythingHealth* (Source: Better Health) Better Health blogs http://www.medworm.com/rss/comments.php?id=3641020 Tue, 08 Jun 2010 14:57:25 +0100 3641020 http://www.medworm.com/index.php?rid=3546996&cid=t_127677_136_f&fid=39026&url=http%3A%2F%2Fcarolinemfr.blogspot.com%2F2010%2F05%2Ffemara.html Now I have switched to Femara from Tamoxifen. Tamoxifen is the gold standard for hormone therapy for Estrogen/Progesterone positive breast cancer. It has been around for thirty years or so. Basically, here my non medical school brain attempts to give a coherent explanation, if your breast cancer is hormone positive, feeding off the hormones, they can suppress the hormones with Tamoxifen for an additional five or more years of treatment. Particularly true for women who were premenopausal.However then there was additional research and aromatase inhibitors were discovered. Currently there are several on the market, Femara, Arimidex, and Aromasin. Research was done and found that women who took Tamoxifen for 2-3 years and then switched to an AI, did just as well or better, than those who staye... Caroline's Breast Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=3546996 Sun, 09 May 2010 11:27:00 +0100 3546996 http://www.medworm.com/index.php?rid=3137558&cid=t_127677_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FoyHN9uIrVs8%2F Women who have had breast cancer may see themselves feeling more sensual and able to enjoy sex if they have acupuncture to treat some of the frustrating side effects of some cancer treatments, such as hot flashes and night sweats, say researchers. Hormone therapy, used to treat some types of breast cancers, is often taken for up to five years after a woman has completed chemotherapy. However, the side effects are often more than simply annoying. They can have a significant impact on quality of life. Not being able to sleep well is the root of many problems at the best of times, but it can be much more difficult when you’re trying to win a battle against a potentially fatal disease. There are medications currently available to counter some of the side effects but they are not always e... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=3137558 Sat, 02 Jan 2010 19:06:22 +0100 3137558 http://www.medworm.com/index.php?rid=3827172&cid=t_127677_117_f&fid=38815&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FGetPrimed%2F%7E3%2F3oNSFqX6Pl0%2F In a previous blog post – Sexual Changes during Perimenopause and Beyond – I reviewed some of the sexual changes that may occur with menopause. One of the most common sexual issue for postmenopausal women is vaginal atrophy (atrophic vaginitis), the thinning and inflammation of vaginal walls induced by declining estrogen. Vaginal atrophy can lead to vaginal dryness and painful sexual intercourse. Although many women do not seek help for this condition, estrogen treatment has been proven effective in restoring vaginal health and improving symptoms. Estrogen Options There are a number of low dose hormone therapies available in a variety of forms such as vaginal tablets, rings and creams. These local therapies relieve dryness and painful intercourse by rebuilding the lining of the vagina... Get Primed! blogs http://www.medworm.com/rss/comments.php?id=3827172 Wed, 30 Dec 2009 16:02:00 +0100 3827172 http://www.medworm.com/index.php?rid=2649111&cid=t_127677_117_f&fid=38815&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FGetPrimed%2F%7E3%2FOR95KvwV9m0%2F Many biological changes occur during perimenopause and continue after menopause, including changes in sexual function. Unfortunately, sexual function and its impact on women’s quality of life is infrequently discussed and rarely addressed during visits with healthcare providers. Women may experience decreased vaginal lubrication, decline in libido (sexual drive) and dyspareunia (painful intercourse). Estrogen levels, which decline with menopause, impact vaginal function, blood flow and secretions. The result can be painful intercourse and a decrease in sexual desire. In some cases, diminishing estrogen can lead to bleeding and formation of adhesions. Taken together, these biological changes can create a range of sexual challenges for women as they age. As a first step, non-hormonal vagin... Get Primed! blogs http://www.medworm.com/rss/comments.php?id=2649111 Fri, 10 Jul 2009 15:24:57 +0100 2649111 http://www.medworm.com/index.php?rid=891626&cid=t_127677_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F159571523%2Fincreased_dosage_of_norditropi_1.html Novo Nordisk A/S announced that it has received approval for its drug, Norditropin, from the FDA. Norditropin is for use on children with Turner's Sydrome. Turner's Syndrome is a rare chromosomal condition that is caused by a complete or partial lack of the X chromosome in girls. Short stature is the most common feature of Turner's and Norditropin targets this. Results from a clinical trial found that 80% of patients receiving a higher than previously approved dosage reach normal adult height."Turner syndrome is a rare chromosomal disorder of females characterizedby short stature and the lack of sexual development at puberty. Amongaffected females, physical features may include a short neck with a webbedappearance, heart defects, kidney abnormalities and various other... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=891626 Fri, 21 Sep 2007 19:00:35 +0100 891626 http://www.medworm.com/index.php?rid=698229&cid=t_127677_131_f&fid=35743&url=http%3A%2F%2Fthegenesherpa.blogspot.com%2F2007%2F06%2Fconfusing-thing-about-association.html This study called the Million Women Study is a large cohort of British women. 948,576 postmenopausal women were assessed for ovarian cancer incidence. Users were 20% more likely to develop Ovarian Cancer. 1 in 5, that seems small, but in a million women (well......just 52k shy) that's alot of cancer!!! Especially such a nasty killer. But here's the kicker....Oral Contraceptive hormones Reduce Colorectal Cancer risk! Wait a second.....Aren't these female hormones too? This study shows an almost 40% reduced incidence of colon cancer in these women from the Women's Health Study. Perhaps this has to do with dosage? But Who Knows....It's an association study!!!Smoking Cuts Risk of Parkinson's Disease So that is what the media says about this study. Ok so now you have got me flipping out. No mec... Gene Sherpas: Personalized Medicine and You blogs http://www.medworm.com/rss/comments.php?id=698229 Tue, 26 Jun 2007 22:58:00 +0100 698229 http://www.medworm.com/index.php?rid=573931&cid=t_127677_135_f&fid=35263&url=http%3A%2F%2Fronhudson.blogspot.com%2F2007%2F04%2Fguest-writers-hlne-hazera-of-act-up.html ConclusionTaking care of the diverse metabolic disorders linked to ARV treatments and theHIV infection have been thoroughly addressed in former publications and will notbe further detailed in this report, which aims at studying the specificities fortranssexuals and their medication.The unique aspects of monitoring the health of transsexuals treated with ARVdrugs lie in the cross-hormonotherapy that characterises them and can lead tomultidirectional interactions and secondary effects. Caution should be exercisedwith protease inhibitors inhibiting cytochrome P450 (efavirenz, indinavir) andwith the associated risk of increasing the hormone levels. It is clear thatpreference should be given to the use 17 beta estradiol percutaneously and thatethinyl estradiol should no longer be used by popula... 2sides2ron blogs http://www.medworm.com/rss/comments.php?id=573931 Fri, 27 Apr 2007 19:59:00 +0100 573931